Advertisement
Advertisement

GANX

GANX logo

Gain Therapeutics Inc

1.54
USD
-0.14
-8.33%
Dec 18, 15:59 UTC -5
Closed
...

Gain Therapeutics Inc Profile

About

Gain Therapeutics Inc. is redefining drug discovery with its See-Tx(TM) target identification platform. It involved in identifying and optimizing allosteric binding sites which have never before been targeted. The company is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding. Gain Therapeutics Inc. is based in BETHESDA, Md.

Info & Links

CEO

Matthias Alder

Headquarters

4800 MONTGOMERY LANE, SUITE 220
BETHESDA, MD 20814, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.gaintherapeutics.com

Auditor

Ernst & Young AG

Share holders

66

Employees

32

Gain Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

40.84M

Enterprise Value

29.29M

Enterprise Value/EBITDA(ttm)

-1.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.67

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-203.91%

Return on Invested Capital(ttm)

-195.95%

Return on Assets(ttm)

-128.05%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-21.34M

Net Income Available to Common(ttm)

-21.37M

Diluted EPS(ttm)

-1.10

Share Statistics

Beta (5Y Monthly)

0.21

52-Week Change

-34.47%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

26.53M

Dividend Yield

0.00%

Float4

23.42M

% Held by Insiders

11.70%

% Held by Institutions

11.97%

Balance Sheet

Total Cash(mrq)

12.05M

Total Cash Per Share(mrq)

0.45

Total Debt(mrq)

494.40K

Total Debt/Equity(mrq)

5.55%

Current Ratio(mrq)

2.99%

Quick Ratio(mrq)

2.99%

Book Value Per Share(mrq)

0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.58

Free Cash Flow(ytd)

-15.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement